Schizophrenia
Welcome,         Profile    Billing    Logout  
 86 Companies   137 Products   137 Products   85 Mechanisms of Action   4 Trials   2019 News 


«12...345678910111213...3940»
  • ||||||||||  Trial completion, Adherence:  Effectiveness of Adherence Therapy for Schizophrenia (clinicaltrials.gov) -  Feb 21, 2016   
    P1/2,  N=134, Completed, 
    Recruiting --> Active, not recruiting Active, not recruiting --> Completed
  • ||||||||||  Aristada once-monthly (aripiprazole lauroxil once-monthly formulation) / Alkermes
    Trial primary completion date:  An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070) (clinicaltrials.gov) -  Feb 16, 2016   
    P3,  N=300, Enrolling by invitation, 
    Active, not recruiting --> Completed Trial primary completion date: Jan 2016 --> May 2016
  • ||||||||||  aripiprazole / Generic mfg., olanzapine / Generic mfg.
    Enrollment closed, Enrollment change, Trial primary completion date, Adverse events:  Assessment of Adverse Events in a Naive Pediatric Population Treated With an Antipsychotic (clinicaltrials.gov) -  Feb 10, 2016   
    P4,  N=200, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Jan 2013 --> Jan 2015 Recruiting --> Active, not recruiting | N=340 --> 200 | Trial primary completion date: Dec 2015 --> May 2016
  • ||||||||||  furosemide / Generic mfg.
    Phase classification:  MRS: The Effect of Plasma Osmolality on Brain Glutamate (clinicaltrials.gov) -  Feb 9, 2016   
    P1,  N=30, Completed, 
    Recruiting --> Active, not recruiting | N=340 --> 200 | Trial primary completion date: Dec 2015 --> May 2016 Phase classification: P1/2 --> P1
  • ||||||||||  Trial primary completion date:  Fingolimod in Schizophrenia Patients (clinicaltrials.gov) -  Feb 8, 2016   
    P2,  N=40, Recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> Dec 2013 Trial primary completion date: Dec 2015 --> Dec 2016
  • ||||||||||  F17464 / Pierre Fabre
    Trial completion, Enrollment change:  F17464 in Acute Schizophrenia Trial (clinicaltrials.gov) -  Jan 27, 2016   
    P2,  N=171, Completed, 
    Recruiting --> Completed | N=40 --> 22 | Trial primary completion date: Dec 2011 --> Jul 2015 Active, not recruiting --> Completed | N=142 --> 171
  • ||||||||||  Trial completion:  Remediation of Working Memory in Schizophrenia (clinicaltrials.gov) -  Jan 22, 2016   
    P=N/A,  N=80, Completed, 
    Recruiting --> Completed | N=20 --> 11 Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Aftercare in the Community Health Center (clinicaltrials.gov) -  Jan 21, 2016   
    P=N/A,  N=41, Completed, 
    Trial primary completion date: Oct 2015 --> Oct 2016 Recruiting --> Completed | N=140 --> 41 | Trial primary completion date: Dec 2015 --> Apr 2015
  • ||||||||||  Trial primary completion date:  STExFx: Short-term Working Memory and Executive Training (clinicaltrials.gov) -  Jan 20, 2016   
    P=N/A,  N=40, Recruiting, 
    Recruiting --> Completed | N=140 --> 41 | Trial primary completion date: Dec 2015 --> Apr 2015 Trial primary completion date: Dec 2015 --> Jun 2016
  • ||||||||||  Trial primary completion date:  The Austrian LEAD (Lung hEart sociAl boDy) Study (clinicaltrials.gov) -  Jan 20, 2016   
    P=N/A,  N=10000, Enrolling by invitation, 
    Trial primary completion date: Nov 2015 --> Jun 2016 Trial primary completion date: Oct 2015 --> May 2016
  • ||||||||||  Rexulti (brexpiprazole) / Lundbeck, Otsuka
    Trial completion, Enrollment change:  Brexpiprazole in Patients With Schizophrenia (clinicaltrials.gov) -  Jan 20, 2016   
    P3,  N=210, Completed, 
    Trial primary completion date: Oct 2015 --> May 2016 Active, not recruiting --> Completed | N=140 --> 210
  • ||||||||||  pregabalin / Generic mfg.
    Trial primary completion date:  PACS: Pregablin for Anxiety-comorbidity in Patients With Schizophrenia (clinicaltrials.gov) -  Jan 17, 2016   
    P4,  N=70, Recruiting, 
    Trial primary completion date: Dec 2015 --> Apr 2016 Trial primary completion date: Feb 2016 --> Dec 2016
  • ||||||||||  Disalcid (salsalate) / Bausch Health
    Trial completion, Enrollment change, Trial primary completion date:  Salsalate as an Adjunctive Treatment for Patients With Schizophrenia (clinicaltrials.gov) -  Jan 15, 2016   
    P4,  N=8, Completed, 
    Active, not recruiting --> Completed | N=58 --> 77 Active, not recruiting --> Completed | N=17 --> 8 | Trial primary completion date: Dec 2015 --> Jul 2015
  • ||||||||||  Trial completion, Enrollment change:  Treatment Development Targeting Severe and Persistent Negative Symptoms (clinicaltrials.gov) -  Jan 15, 2016   
    P=N/A,  N=96, Completed, 
    Active, not recruiting --> Completed | N=17 --> 8 | Trial primary completion date: Dec 2015 --> Jul 2015 Active, not recruiting --> Completed | N=50 --> 96
  • ||||||||||  lurasidone / Generic mfg.
    Trial completion:  Pediatric Schizophrenia Efficacy and Safety Study (clinicaltrials.gov) -  Jan 11, 2016   
    P3,  N=285, Completed, 
    Recruiting --> Completed | N=40 --> 20 Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change:  Shared Decision Making for Patients With First-admission Schizophrenia (clinicaltrials.gov) -  Dec 30, 2015   
    P2/3,  N=23, Completed, 
    Initiation date: Sep 2013 --> Dec 2013 | Trial primary completion date: Sep 2016 --> Dec 2018 Active, not recruiting --> Completed | N=52 --> 23
  • ||||||||||  Trial completion, Trial primary completion date:  Efficacy of Pregnenolone in Patients With Schizophrenia (clinicaltrials.gov) -  Dec 21, 2015   
    P2,  N=100, Completed, 
    Active, not recruiting --> Completed | N=648 --> 336 Active, not recruiting --> Completed | Trial primary completion date: Jul 2013 --> Dec 2014
  • ||||||||||  tolcapone / Generic mfg.
    Trial completion:  Clinical Trial of Tolcapone for Cognition in Schizophrenia (clinicaltrials.gov) -  Dec 17, 2015   
    P2,  N=212, Completed, 
    Active, not recruiting --> Completed | N=180 --> 400 | Initiation date: Apr 2004 --> Mar 2015 Recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Efficacy Study of GA (clinicaltrials.gov) -  Dec 16, 2015   
    P=N/A,  N=47, Completed, 
    Trial primary completion date: Jan 2016 --> Jun 2016 Recruiting --> Completed | N=100 --> 47 | Trial primary completion date: Sep 2014 --> Oct 2015
  • ||||||||||  olanzapine / Generic mfg., sertraline / Generic mfg.
    Trial primary completion date:  STOP-PD: Sustaining Remission of Psychotic Depression (clinicaltrials.gov) -  Dec 14, 2015   
    P4,  N=392, Recruiting, 
    N=1400 --> 2292 Trial primary completion date: Jan 2016 --> Mar 2017
  • ||||||||||  Enrollment closed, Trial primary completion date:  Assertive Community Treatment With CBT and SST for Schizophrenia (clinicaltrials.gov) -  Dec 14, 2015   
    P=N/A,  N=176, Active, not recruiting, 
    Trial primary completion date: Jan 2016 --> Mar 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2016 --> Aug 2016